Physician profile
Austin T Stack
NPI 1649880352
$3,204.90
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,480 · 2022: $1,615 · 2023: $43.80 · 2024: $65.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $420.51 | 2021-2024 | |
| Amarin Pharma, INC. | $371.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $354.53 | 2021-2022 | |
| Amgen INC. | $278.13 | 2021-2022 | |
| Novo Nordisk INC | $242.99 | 2021-2022 | |
| Medtronic, INC. | $218.26 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $182.80 | 2021-2022 | |
| Edwards Lifesciences Corporation | $181.85 | 2022 | |
| Eisai INC. | $149.16 | 2021-2022 | |
| Esperion Therapeutics, INC. | $107.63 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $101.29 | 2021-2022 | |
| Pfizer INC. | $98.15 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.31 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $79.99 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.01 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.11 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $44.68 | 2021-2022 | |
| Sanofi Pasteur INC. | $38.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $25.82 | 2021 | |
| Amryt Pharma Holdings Ltd | $22.53 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.89 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.11 | 2021 | |
| Vistapharm, INC. | $13.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Stack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.